Pharmafile Logo
  • - PMLiVE
  • - PMLiVE
  • Diversity, Equity and Inclusion
  • Communiqué 53 Cover Image

Glaucoma in perspective

Celgene building

FDA turns down Celgene’s filing for multiple sclerosis drug

The application needs additional pharmacology information according to the US agency

- PMLiVE

Mereo BioPharma appoints head of patient access and commercial planning

Wills Hughes-Wilson joins the group from Sobi

- PMLiVE

Lynn Lewis joins Envigo

She becomes the CRO’s senior vice president of global sales

- PMLiVE

Vivid Medical Communications Supports the 10th Anniversary of Rare Diseases Day 2018

Vivid Medical Communications – a newly created rare diseases specialist agency and part of the successful Lucid Group of companies – is a proud supporter of Rare Diseases Day 2018.

Lucid Group Communications Limited

Rare Disease Day 2018: Five things you should know about rare diseases.

To help raise awareness for Rare Disease Day, Porterhouse Medical describes five interesting facts about rare diseases

Porterhouse Medical Group

- PMLiVE

The challenges of making genomics a reality for patients today, not tomorrow

Creating transformative medicines

Bridging pharma’s digital gap

Although still playing catch-up, the industry is being transformed by technology

Eli Lilly HQ

FDA backs earlier use of Lilly’s breast cancer drug Verzenio

Studies show the drug improves PFS when used with an aromatase inhibitor

Six Factors to Consider When Designing Advisory Boards

Designing engaging, efficient and effective advisory boards is a complex task. You need to convince key opinion leaders from around the world to take time out of their busy schedules...

Six Degrees Medical Consulting

Bristol-Myers Squibb (BMS) building

Yale Cancer Center joins BMS’ II-ON

Becomes the 16th institute to join the network

- PMLiVE

Kelly Warth joins the P/S/L Group network

She becomes managing director for Instar Europe

- PMLiVE

Prescient names vice president global head of advisory

Dr Debasish Talukdar joins the consultancy from Bain & Company

Subscribe to our email news alerts

Latest content

Latest intelligence

Quick links